Category: Stock Market

The S&P/ASX 200 Index (ASX: XJO) traded in the red on Friday despite an exuberant performance from energy shares. The index closed today’s session 0.54% lower at 7,032.5 points.

That left the benchmark index just 0.2% higher than where it ended last week after reaching its highest closing price in two months on Thursday.

The S&P/ASX 200 Energy Index (ASX: XEJ) was alone in the green today, gaining 2.3%.

The price of thermal coal lifted 0.6% to US$401 per tonne overnight. Meanwhile, the Brent crude oil price rose 2.3% to US$99.60 per barrel and the US Nymex crude price increased 2.6% to $94.34 a barrel.

On the other end of the market, the S&P/ASX 200 Real Estate Index (ASX: XRE) and the S&P/ASX 200 Information Technology Index (ASX: XIJ) fell 2% and 1.8% respectively.

The S&P/ASX 200 Materials Index (ASX: XMJ) also slumped 0.7%, weighed down by the Lake Resources N.L. (ASX: LKE) share price’s about-face.

It came after gold futures fell 0.4% to US$1,807.20 an ounce while iron ore futures lifted 1.6% to $111.01 overnight.

All in all, only one of the ASX 200’s 11 sectors was in the green at the end of Friday’s trade. But which share outperformed all others to end the week with a bang? Keep reading to find out.

Top 10 ASX 200 shares countdown

Today’s best performing ASX 200 share was gold explorer and developer De Grey Mining Limited (ASX: DEG). The stock continued a recent green streak to gain 3.7% on Friday.

Find out what De Grey has been up to lately here.

Today’s biggest gains were made by these ASX shares:

ASX-listed company	Share price	Price change
Woodside Energy Group Ltd (SAX: WDS)	$32.77	3.74%
New Hope Corporation Limited (ASX: NHC)	$4.40	3.53%
Beach Energy Ltd (ASX: BPT)	$1.85	3.06%
De Grey Mining Limited (ASX: DEG)	$1.035	2.99%
TPG Telecom Ltd (ASX: TPG)	$6.63	2.79%
Viva Energy Group Ltd (ASX: VEA)	$2.78	2.58%
Whitehaven Coal Ltd (ASX: WHC)	$6.62	2.48%
GUD Holdings Limited (ASX: GUD)	$9.00	2.27%
Costa Group Holdings Ltd (ASX: CGC)	$2.79	2.2%
Incitec Pivot Ltd (ASX: IPL)	$3.74	2.19%

Our top 10 ASX 200 shares countdown is a recurring end-of-day summary to let you know which companies were making big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• The A2 Milk share price has had a tough week. Could this other ASX dairy company cash in?
• Here are the 3 most heavily traded ASX 200 shares on Friday
• Is this why the NIB share price is lagging Medibank on Friday?
• Why 5E Advanced Materials, IAG, Magnis, and Woodside shares are pushing higher
• Why are ASX coal shares having such a stellar end to the week?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended COSTA GRP FPO and TPG Telecom Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/qSvuG8B

It’s been a gloomy end to the trading week for the S&P/ASX 200 Index (ASX: XJO). The ASX 200 slid by 0.77% to close on Friday at 7,023.5 points.

The A2 Milk Company Ltd (ASX: A2M) share price had a slightly happier ending. After a bouncy trading day, the ASX 200 dairy company enjoyed a 0.4% finishing boost to close on Friday at $4.90 a share.

However, the past week overall has not been kind for A2 Milk shares. The company started the week at $5.06 a share. This means that A2 shares have gone backwards by more than 3% over this week.

Much of this negative sentiment appeared to flow on from the announcement the company made on Wednesday.

This informed investors that the US Food and Drug Administration (FDA) was “deferring further consideration for an enforcement discretion to import infant milk formula (IMF) products into the United States”. That includes A2 Milk, as well as any other aspirant.

The US is currently facing a severe shortage of baby formula products. Investors had hoped that A2 Milk would be granted FDA approval to ramp up baby formula exports to the country.

Its fellow dairy company Bubs Australia Ltd (ASX: BUB) made some progress in May. But Wednesday’s announcement made it clear that this wouldn’t be happening any time soon for A2 Milk.

A2 Milk shares miss out, but not so for this competitor…

So the A2 Milk share price seems to have lucked out in this regard. But the same can’t be said for another of A2 Milk’s competitors.

Australian Dairy Nutritionals Group (ASX: AHF) is a minnow compared to A2 Milk, with a market capitalisation of just under $40 million (compared with A2’s $3.62 billion at present).

But Australian Dairy has something A2 doesn’t. That would be an FDA application still under “active review”. According to an ASX release put out today, the company has stated the following:

Contrary to certain media articles which have suggested that all pending applications to the United States Food and Drug Administration (FDA) for accelerated approval to sell infant formula in the United States have been paused, the Board of Australian Dairy Nutritionals Group… is pleased to advise that the FDA has confirmed that AHF’s FDA application in relation to its future Gradulac Gentle infant formula range remains under active review.

We understand the FDA sent out a deferral letter to many applicants whose application will not be progressed at this time however AHF did not receive this letter and the FDA has confirmed our application is still under active review.

Like A2, Australian Dairy also produces A2 dairy products, in this case organically. So it is interesting to see Australian Dairy have its application to the FDA get an “active review”, where A2 Milk did not.

Whatever the reasons for this situation, it has certainly put a dampener on the A2 Milk share price’s trading week this week.

The post The A2 Milk share price has had a tough week. Could this other ASX dairy company cash in? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the top 10 ASX 200 shares today
• Here are the 3 most heavily traded ASX 200 shares on Friday
• Is this why the NIB share price is lagging Medibank on Friday?
• ASX shares are rallying! Here’s what to do now: experts
• Down 20% since March, is this ASX 200 share a misunderstood investment opportunity?

Motley Fool contributor Sebastian Bowen has positions in A2 Milk. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/e6LthWs

The Qantas Airways Limited (ASX: QAN) share price is slightly in the red today.

The travel company’s shares are down 0.43% and currently trading at $4.67. For perspective, the S&P/ASX 200 Industrials Index (ASX: XNJ) is falling 0.85%.

Let’s take a look at what is happening at Qantas.

Plan to resolve challenges

The Qantas share price is not the only ASX travel share struggling to take off today. The Flight Centre Travel Group Ltd (ASX: FLT) is descending 1.28%, while Webjet Limited (ASX: WEB) shares are down 0.23%

Qantas has reportedly sent a note to major corporate clients acknowledging its well publicised challenges.

The airline has plans to spend $15 million on technology, hire more staff, roster more workers, modify the schedule and improve baggage.

In quotes cited by The Australian, Qantas chief information office Sam Charmand said:

Since the pandemic we have seen a huge jump in customers choosing to use technology when travelling, which is why we’re investing more in our app and airport technology.

These upgrades will also make things easier for our airport teams, who have done a
phenomenal job in recent months under challenging circumstance.”

Meanwhile, Qantas engineers are considering a strike as soon as Monday relating to pay, 9 News reported yesterday. The Qantas staff are seeking a 12% pay rise.

Recently, news emerged Qantas has a plan to recruit 100 managers to work as ground handlers.

Qantas share price snapshot

The Qantas share price has climbed more than 3% in a year but lost nearly 7% year to date.

In comparison, the ASX 200 Industrials benchmark has jumping 1.35%, while it has fallen 2.5% year to date.

Qantas has a market capitalisation of about $8.8 billion based on the current share price.

The post Qantas share price unimpressed despite $15m solution to ‘well-publicised challenges’ appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Better ASX travel buy: Flight Centre or Webjet?
• Why did the Qantas share price fly higher today?
• Why is the Qantas share price beating the ASX 200 today?
• It’s gained 60% in 2 years, does the Webjet share price still have room to grow?
• Are we flying first class with Flight Centre shares?

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited and Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/hc0HwW7

The Dogecoin (CRYPTO: DOGE) price is down 1% since this time yesterday but remains up 5% over the full week.

At the time of writing, the crypto – which features a Shiba Inu as its virtual mascot — is trading for 7.11 US cents. That gives Dogecoin a market cap of US$9.44 billion, making it the 11th biggest crypto in circulation.

As you’d likely expect, there was plenty of volatility on display over the week, with the Dogecoin price trading as low as 6.74 US cents and as high as 7.39 US cents, a range of 10%, according to data from CoinMarketCap.

While the 4% weekly gain will certainly be welcomed by crypto investors, the meme token has a long way to go to recoup its 8 May 2021 all-time highs of 73.76 US cents.

What helped drive the Dogecoin price higher this week?

The Dogecoin price looks to have received some healthy tailwinds on two fronts.

First, the broader rally in risk assets that ensued after inflation figures out of the United States came in lower than consensus expectations.

While the tech-heavy NASDAQ has given back some of those gains, the index (a good gauge of investor risk appetite) is up 1.4% over the week.

The resurgent risk appetite may be temporary, but it’s seen the majority of cryptos gain over the week.

The Bitcoin (CRYPTO: BTC) price is up 4% over the past seven days. One Bitcoin is currently trading for US$23,960.

And when Bitcoin rises, the price of altcoins like Dogecoin tend to follow suit.

Bitcoin gets a lift from Blackrock

The Bitcoin price, and by correlation the Dogecoin price, also received a boost this week from BlackRock, the world’s largest asset manager.

Yesterday (overnight Aussie time), BlackRock revealed it will offer its institutional clients the option to invest in a new, private Bitcoin trust.

According to BlackRock (courtesy of Bloomberg):

Despite the steep downturn in the digital-asset market, we are still seeing substantial interest from some institutional clients in how to efficiently and cost-effectively access these assets using our technology and product capabilities.

Though BlackRock is currently limiting its exposure to Bitcoin, the Dogecoin price leapt to seven-day highs following the news.

The post Here’s why the Dogecoin price has had such a great week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Ethereum, Bitcoin, and Dogecoin jumped this morning
• Why Bitcoin and Ethereum are rising today
• Why this Bitcoin maximalist says all other ‘crypto is a scam’
• Why Bitcoin, Ethereum, and Shiba Inu are falling today
• Can the Bitcoin price reach US$30,000 again in 2022?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin. The Motley Fool Australia has positions in and has recommended Bitcoin. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/6iABqMt

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Domino’s Pizza Enterprises Ltd (ASX: DMP)

According to a note out of Citi, its analysts have retained their buy rating and $92.95 price target on this pizza chain operator’s shares. This follows news that another Domino’s fanchisee, ePizza, has closed down its operations in Italy. Citi sees this as a potential opportunity for the company to expand into the market to take its place. The broker believes its existing European infrastructure could give it a greater chance of success in the country. The Domino’s share price is trading at $69.44 today.

Pilbara Minerals Ltd (ASX: PLS)

Another note out of Citi reveals that its analysts have retained their buy rating and lifted their price target on this lithium miner’s shares to $3.60. The broker made the move after increasing its earnings forecasts for FY 2023 and FY 2024 materially on the back of higher spodumene price assumptions. The Pilbara Minerals share price is fetching $3.08 on Friday afternoon.

Telstra Corporation Ltd (ASX: TLS)

Analysts at Morgans have retained their add rating and lifted their price target on this telco giant’s shares to $4.60. This follows the release of a full year result that Morgans described as “good”. The broker was also pleased to see that the company’s FY 2023 guidance was in line with market expectations. Outside this, Morgans highlights that Telstra has the strongest tailwinds in a decade. The Telstra share price is trading at $3.99 on Friday.

The post Brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the 3 most heavily traded ASX 200 shares on Friday
• Up 52% since June, can the Pilbara Minerals share price extend gains?
• Is the Telstra share price a buy after the telco’s FY22 results?
• Why AMP, OFX, Rio Tinto, and Telstra shares are dropping
• Equity markets threaten to ‘melt up’ as Nasdaq enters bull market territory

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8xLGYN5

After rallying yesterday, it seems the S&P/ASX 200 Index (ASX: XJO) is determined to finish this week’s trading on a negative note. At the time of writing, the ASX 200 has lost a depressing 0.65% and is back to around 7,025 points.

The post Here are the 3 most heavily traded ASX 200 shares on Friday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Is this why the NIB share price is lagging Medibank on Friday?
• Lake Resources share price finally slumps after jumping 72% this week
• New records and looming deficits. Why ASX lithium stocks are in the spotlight
• Is the Telstra share price a buy after the telco’s FY22 results?
• ASX shares are rallying! Here’s what to do now: experts

Motley Fool contributor Sebastian Bowen has positions in Telstra Corporation Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/NhUjVd1

The NIB Holdings Limited (ASX: NHF) share price is in reverse today following a morbid day on the ASX.

Shares in the private health insurer are down 1.11% to $7.11.

In comparison, the S&P/ASX 200 Index (ASX: XJO) is 0.72% lower at around 7,020 points.

Adding to its misfortune, the NIB share price is trailing behind its rival, Medibank Private Ltd (ASX: MPL). The latter’s shares are down just 0.43% to $3.465 apiece.

Let’s take a look at what could be causing this discrepancy between shares in the two companies.

NIB backtracks as Medibank makes policy changes

The NIB share price appears to be suffering at the hands of a broader fall across the ASX.

However, its competitor, Medibank, is largely shrugging off the sell-off following news that it has extended its policy coverage.

According to The Australian, Medibank and its subsidiary ahm are entending the age of adult dependants on their parents’ policy from 25 to 31.

As of next Thursday, young adults up to the age of 31 will be able make claims on their parents’ extras and hospital cover.

The decision to adjust the policy is to help alleviate financial stress as the cost of living has risen sharply.

Medibank is hoping to retain younger Aussies as recent data has shown that this demographic is steadily dropping off private health cover.

When the young adults do turn 31, the lifetime health cover loading (LHC) will kick in. This is where an annual 2% loading penalty is applied to private hospital premiums for every year you do not have cover.

It is worth noting that the LHC only relates to hospital insurance policies.

Whether or not NIB will quickly follow suit remains to be seen.

The company covers adult children up to the age of 25 if they are full-time students or on extended family policies at an extra cost.

NIB share price summary

In 2022, the NIB share price has moved in circles on the back of inflationary pressure and volatility on the ASX.

The company’s shares are relatively flat for the period, but down 7% when looking at the past 12 months.

Based on today’s price, NIB commands a market capitalisation of roughly $3.30 billion.

The post Is this why the NIB share price is lagging Medibank on Friday? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the 3 most heavily traded ASX 200 shares on Friday
• ASX shares are rallying! Here’s what to do now: experts
• Down 20% since March, is this ASX 200 share a misunderstood investment opportunity?
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Teboneras has positions in NIB Holdings Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/MkEB0Q9

The Resmed CDI (ASX: RMD) share price is down around 3.5% at $33.42 in afternoon trading. This comes after the US-based sleep apnoea medical device company released its full-year results to the ASX this morning.

As my colleague James wrote, ResMed Inc (NYSE: RMD) booked a 12% increase in revenue year over year to US$3.6 billion. It finished the year with an underlying net profit of US$850.8 million, up 9% on FY21.

Revenue and profits up

As James points out, ResMed’s underlying net profit was slightly above market consensus expectations of US$825.6 million.

A recall by competitor Royal Philips in June 2021 provided a revenue boost for ResMed in FY22.

Management estimates that US$60 million to US$70 million in incremental fourth-quarter revenue was related to the recall. That implies an annual total of US$220 million to US$260 million.

Inflation started to bite in FY22, with higher freight and manufacturing costs impacting margins.

Over FY22, the Resmed share price slipped by about 7%.

Resmed dividends up

ResMed declared a final quarterly cash dividend of 44 US cents, up 5% on the prior corresponding period. But that’s what ResMed Inc shareholders (owners of the NYSE-listed shares) will get. It’s different for ASX shareholders, who own Resmed CDI shares.

Remember ResMed is a US-domiciled company listed on the New York Stock Exchange. The Resmed shares listed on the ASX are CHESS depositary interests (CDIs) which “confer a beneficial interest in the underlying financial product to which it relates”, explains the ASX.

This beneficial interest is on a ratio of 10:1 for owners of the ASX shares. So, Resmed CDI shareholders will receive 4.4 US cents per share as dividends. This currently converts to 6.2 cents in Australian currency. The payment date is 22 September.

So, why is the Resmed share price down?

The company exceeded consensus profit expectations, and it’s going to pay a higher dividend this year. So why is the Resmed share price down?

Well, the dip might not have anything to do with investors’ reactions to the results. The market as a whole is down today.

The S&P/ASX 200 Index (ASX: XJO) is off 0.73% and the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 1.81%.

In fact, health care is the second worst performing sector today behind the S&P/ASX 200 A-REIT Index (ASX: XPJ), which is down 1.87%. The only sectors in the green are energy and communications.

So, it might simply be a case of the Resmed share price being dragged down, along with many other ASX healthcare shares, by the broader sector and market today.

The post Resmed share price dips despite profit and dividend boost appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Baby Bunting, PointsBet, ResMed, and Suncorp shares are dropping today
• ResMed share price on watch following solid FY22 growth
• 5 things to watch on the ASX 200 on Friday
• $20,000 invested in these ASX shares 10 years ago is worth how much now?
• Brokers name 3 ASX shares to buy today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/HkurQ2t

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 0.7% to 7,020.1 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is down 4% to $4.66. This follows the release of the baby products retailer’s full year results. Baby Bunting reported an 8.3% increase in sales to $507.3 million and a 14.6% lift in net profit after tax to $19.4 million. The latter falls short of the consensus estimate of $25.2 million.

PointsBet Holdings Ltd (ASX: PBH)

The PointsBet share price is down 6% to $3.57 despite there being no news out of the sports betting company. However, it is worth noting that the tech sector is a sea of red today following a poor night of trade on the NASDAQ index. This has seen the S&P/ASX All Technology Index drop by 1.5% this afternoon.

ResMed Inc (ASX: RMD)

The ResMed share price is down 3.5% to $33.38. Investors have been selling this sleep treatment company’s shares following the release of its full year results. This is despite Goldman Sachs noting that its fourth quarter “Revenue [was] in-line; earnings +4% ahead.” For the full year, ResMed reported a 12% (13% in constant currency) increase in revenue to US$3.6 billion and a 9% lift in non-GAAP net income to US$850.8 million.

Suncorp Group Ltd (ASX: SUN)

The Suncorp share price is down 3.5% to $11.18. Today’s decline has been driven by the insurance giant’s shares trading ex-dividend this morning for its upcoming final dividend. Eligible shareholders can now look forward to receiving its 17 cents per share fully franked dividend next month on 21 September.

The post Why Baby Bunting, PointsBet, ResMed, and Suncorp shares are dropping today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Resmed share price dips despite profit and dividend boost
• Why is the Suncorp share price slipping today?
• ‘Our future is looking bright’: Baby Bunting share price slips despite earnings milestone
• ResMed share price on watch following solid FY22 growth
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pointsbet Holdings Ltd and ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Baby Bunting and Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/H8lO91g

The Enero Group Ltd (ASX: EGG) share price is gaining significant ground today following the release of a positive earnings report for FY22 this morning. 

At the time of writing, Enero shares are up 7.14% to $3.30 apiece.

The global marketing group reported revenue and bottom line profitability growth in its operating segments.

Value from the growth of these segments was transferred to its balance sheet, adding a large amount of cash and boosting net assets.

The outlook for FY23 is also positive, focusing on improving its existing book of business and realising synergy with its recently acquired companies.

What did Enero report?

Investors are pushing up the Enero share price on the back of a strong full-year result for FY22. Highlights include:

• Net revenue up 20.4% from FY21 to $193.4 million
• Operating earnings before interest, taxes, depreciation, and amortisation (EBITDA) up 36.4% from FY21 to $62.2 million
• Operating EBITDA margin up 380bps to 32.2%
• Earnings per share (EPS) up 17% to 30.9 cents

Enero reported strong EBITDA and net revenue growth for both its brand transformation and creative technology operating segments.

Net revenue for brand transformation increased by 11.3% to $106.7 million, while operating EBITDA increased by 13.6% to $24.2 million.

Net revenue for creative technology and data had a larger percentage increase of 34%, growing to $86.7 million. Operating EBITDA was also higher, with a 52.8% increase to $48.6 million.

The company also announced a dividend per share of 12.5 cents, which was down from 14.9 cents in FY21.

What else happened?

Enero strengthened its balance sheet, adding $48 million in cash to it in FY22. Net assets also grew 14.93% to $155.3 million. 

By adding digital transformation services to its product mix, Enero estimates it has a $1.2 trillion new addressable market, up from $488 billion through offering solely marketing services.

A fully franked final dividend of 6.5 cents was announced, which is a 48% increase on FY21’s final dividend. The dividend has a record date of September 20 and a payment date of October 4 this year.

What did management say?

Commenting on the results which have helped push up the Enero share price today, CEO Brent Scrimshaw said:

Throughout FY22 our global portfolio of innovative brands and services delivered strong operating results, continuing our trajectory of sustainable growth in revenue and earnings over the past five years.

In line with our operational strategy, Enero’s revenue base is now highly diversified across segments, industries, and clients.

What’s next?

Enero’s priorities for FY23 include improving its existing book of business and developing a focus on environmental, social, and corporate governance.

Enero said it would also integrate its most recent acquisitions into the business. Companies ROI DNA Inc, a B2B sales & marketing agency, and GetIT Ltd, a B2B technology marketing agency, were acquired at the start of July this year.

A focus on driving efficiency was also cited as a priority. This will reportedly be achieved through new processes and improved cost management.

Enero share price snapshot

The Enero share price has increased by 10% over the past 12 months.

Shares in the company are beating the S&P/ASX 200 Communication Services Index (ASX: XTJ) by a wide margin — it’s currently down 3% over the last year.

Enero has a market capitalisation of $274.78 million.

The post Enero share price jumps 7% as earnings rocket appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why 5E Advanced Materials, IAG, Magnis, and Woodside shares are pushing higher
• Origin share price dips amid fresh climate pressure from shareholders
• Everything you need to know about the latest IAG dividend
• Why are ASX coal shares having such a stellar end to the week?
• The CBA share price has been making big news this week. What can ASX 200 investors expect next?

Motley Fool contributor Mtthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/QfFIDm3